Please wait while we open this resource.
K
Medicines & prescribing
Cost Effective Heart Failure Care - St. Mary's Lacor
Medical Department, St Mary’s Hospital, Lacor
PDF202629 pages9.9 MB
The document outlines the local burden of heart failure, distinguishing HFREF and HFPEF phenotypes and their echocardiographic criteria. It evaluates the applicability of ESC/AHA guidelines in a low‑resource setting and proposes affordable medication regimens, including hydralazine‑ISDN, sacubitril‑valsartan, SGLT2 inhibitors, and beta‑blockers. Clinical decision flowcharts and mobile‑app concepts are presented to aid clinicians in tailoring therapy to patient phenotype, stability, and budget. The guide also highlights interdisciplinary collaboration, pharmacy‑led titration, and potential research directions for the region.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Cardio Oncology Practice Manual A Companion to Braunwalds Heart
Same clinical topic · Cardiology
The Heart-Brain Connection
Same clinical topic · Cardiology
Cardiology in the ER: A Practical Guide
Same clinical topic · Cardiology
NITROGLYCERIN (GLYCERYL TRINITRATE): DRUG INFORMATION
Same clinical topic · Cardiology
CLOPIDOGREL: DRUG INFORMATION
Same clinical topic · Cardiology
SACUBITRIL AND VALSARTAN: DRUG INFORMATION
Same clinical topic · Cardiology
CRITERIA FOR THE DIAGNOSIS OF CARDIOGENIC SHOCK—EUROPEAN PERSPECTIVE: A CLINICAL CONSENSUS STATEMENT
Same specialty · Cardiology
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Same specialty · Cardiology
2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure
Same specialty · Cardiology